Boehringer Ingelheim
Category: Autre
mise à jour avec succès: 26 avr. 2022
Auteurs
Created byVladyslav Fesenko
Attachments
Les événements
Abexxa Biologics, Cancer Immunotherapy ResearchNorthern Biologics, Therapeutic Antibodies Targeting TumoursStake at Hikma Pharmaceuticals, Pharmaceuticals ManufacturingConsumer Health Division to SanofiViraTherapeutics, Viral Cancer Therapy DeveloperAmal Therapeutics SA, Cancer Immunotherapy and Vaccine TreatmentsICD Therapeutics, Drug DeliveryNBE Therapeutics, Antibody-Drug Conjugates and Advancing Targeted Cancer TherapiesLabor Dr. Merk & Kollegen, Immuno-Oncology TherapyGlobal Stem Cell Technology, Animal HealthMerial, Animal Health DivisionUS Pet Vaccines Business to ElancoSSP CO, OTC DrugsBoehringer Ingelheim Shionogi VetmedicaSTEAG microParts GmbH, Microsystem TechnologyActimis Pharmaceuticals, Asthma and Allergy Drugs DeveloperFort Dodge, Animal HealthRoxane Business to HikamaDr. Karl Thomae GmbH, PharmaceuticalsPfizer's veterinary programmeAmgen's Fremont Manufacturing and R&D facilitySaint-Herblon Manufacturing Facility and the Coophavet brand to Dopharma
Comments